Shelter Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE013V01011
  • NSEID:
  • BSEID: 543963
INR
37.60
-1.3 (-3.34%)
BSENSE

Dec 05

BSE+NSE Vol: 21000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Shelter Pharma Ltd stock-summary
stock-summary
Shelter Pharma Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Shelter Pharma Limited originally named as 'Shelter Pharmacy', was converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company under the name "Shelter Pharma Limited" on 12 October, 2007 with the Registrar of Companies, Gujarat. The Company primarily focuses in manufacturing of ayurvedic and herbal products with well-built presence in Human Pharma as well as Veterinary space. The Company started with a few products about decades back.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 11.56 Cr
Number of Shares
1.16 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
18-Aug-2023
1.16
11.56
3816000
10
Public Issue
27-Feb-2023
77.44
7.74
7259805
10
Bonus Issue
15-Sep-2020
4.84
0.48
30000
10
Right Issues
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Shakil Nisarahmed Sabugar (13.53%)

Highest Public shareholder

Rifat Misbah Panchbhai (3.07%)

Individual Investors Holdings

49.32%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Materials Consumed
37.1535
0%
 
100
Cost of Materials Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 64 Cr (Micro Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.55%

stock-summary
Debt Equity

-0.07

stock-summary
Return on Equity

11.93%

stock-summary
Price to Book

1.05